Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer
Clinical trial NCT05163223 · TERMINATED
Trial details
- NCT number
- NCT05163223
- Sponsor
- Aston Sci. Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2024-05-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.